RJA
RMTI icon

Raymond James & Associates’s Rockwell Medical RMTI Stock Holding History

Raymond James & Associates’s Portfolio RMTI Stock Details RMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$81K Buy
+2,040
New +$54.9K ﹤0.01% 3806
2024
Q1 		– Sell
-22,098
Closed -$418K – 4018
2023
Q4 		$418K Buy
22,098
+3,031
+16% +$56.9K ﹤0.01% 3063
2023
Q3 		$397K Buy
19,067
+14,285
+299% +$434K ﹤0.01% 3028
2023
Q2 		$261K Sell
4,782
-1,200
-20% -$36.9K ﹤0.01% 3340
2023
Q1 		$108K Buy
+5,982
New +$103K ﹤0.01% 3635
2022
Q2 		– Sell
-427
Closed -$22K – 4191
2022
Q1 		$22K Buy
427
+100
+31% +$4.24K ﹤0.01% 3992
2021
Q4 		$15K Sell
327
-113
-26% -$6.05K ﹤0.01% 4051
2021
Q3 		$29K Sell
440
-53
-11% -$4.02K ﹤0.01% 3969
2021
Q2 		$49K Buy
493
+22
+5% +$2.27K ﹤0.01% 3919
2021
Q1 		$60K Hold
471
– – ﹤0.01% 3839
2020
Q4 		$52K Buy
471
+74
+19% +$8.29K ﹤0.01% 3625
2020
Q3 		$47K Sell
397
-1
-0.3% -$173 ﹤0.01% 3452
2020
Q2 		$85K Sell
398
-114
-22% -$26.9K ﹤0.01% 3321
2020
Q1 		$115K Buy
512
+199
+64% +$56.7K ﹤0.01% 3190
2019
Q4 		$84K Sell
313
-35
-10% -$8.8K ﹤0.01% 3495
2019
Q3 		$106K Sell
348
-4
-1% -$1.23K ﹤0.01% 3382
2019
Q2 		$117K Sell
352
-10
-3% -$5.08K ﹤0.01% 3387
2019
Q1 		$226K Buy
362
+58
+19% +$26.5K ﹤0.01% 3164
2018
Q4 		$76K Sell
304
-942
-76% -$375K ﹤0.01% 3345
2018
Q3 		$578K Buy
1,246
+80
+7% +$38.7K ﹤0.01% 2613
2018
Q2 		$632K Buy
1,166
+433
+59% +$260K ﹤0.01% 2523
2018
Q1 		$420K Buy
733
+101
+16% +$63.7K ﹤0.01% 2678
2017
Q4 		$405K Buy
632
+5
+0.8% +$3.52K ﹤0.01% 2660
2017
Q3 		$590K Hold
627
– – ﹤0.01% 2384
2017
Q2 		$547K Sell
627
-45
-7% -$36.9K ﹤0.01% 2358
2017
Q1 		$463K Buy
672
+26
+4% +$17.1K ﹤0.01% 2424
2016
Q4 		$465K Buy
646
+68
+12% +$47K ﹤0.01% 2380
2016
Q3 		$426K Sell
578
-97
-14% -$78.5K ﹤0.01% 2387
2016
Q2 		$562K Sell
675
-279
-29% -$259K ﹤0.01% 2049
2016
Q1 		$788K Buy
954
+565
+145% +$444K ﹤0.01% 1793
2015
Q4 		$439K Sell
389
-15
-4% -$17.4K ﹤0.01% 2057
2015
Q3 		$343K Sell
404
-1,134
-74% -$1.64M ﹤0.01% 2091
2015
Q2 		$2.73M Buy
1,538
+1,197
+351% +$1.52M 0.01% 1152
2015
Q1 		$410K Buy
341
+35
+11% +$41K ﹤0.01% 2117
2014
Q4 		$346K Buy
+306
New +$314K ﹤0.01% 2076

Other funds holding RMTI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Raymond James & Associates's RMTI Position: Q3 2024 in Review

Raymond James & Associates opened a new position in Rockwell Medical (RMTI) in Q3 2024: 2,040 shares worth $81K. The stake represents ﹤0.01% of the portfolio and ranks #3806 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in RMTI as recently as Q4 2023.

Raymond James & Associates first reported a position in RMTI in Q4 2014 and has held it in 35 quarters since. The position peaked at $2.73M in Q2 2015. 53 funds tracked by Wall St. Rank hold RMTI as of Q3 2024.

  • Raymond James & Associates held 2,040 shares of Rockwell Medical worth $81K as of Q3 2024.
  • Rockwell Medical was a new Raymond James & Associates position in Q3 2024.
  • Rockwell Medical made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3806 holding.
  • Raymond James & Associates first reported a position in Rockwell Medical in Q4 2014 and has held it in 35 quarters since.
  • Raymond James & Associates's Rockwell Medical position peaked at $2.73M in Q2 2015.
  • 53 funds tracked by Wall St. Rank held Rockwell Medical as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.